RECRUITING

Surveillance Versus Bronchoscopy After Airway Stenting

Conditions

Bronchial Stents Airway Stent Bronchoscopy Surveillance

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Randomized, pilot study that evaluates surveillance bronchoscopy versus no surveillance for patients that undergo tracheobronchial stenting

Official Title

Surveillance Versus Prn bronChOscoPy aftEr aIrway stenTing (SCOPE-IT)

Quick Facts

Study Start:2025-01-01

Study Completion:2026-03-31

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT06935695

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* All adult patients that undergo central airway (trachea, main stem bronchi and bronchus intermedius) stenting.	* Inability to obtain informed consent due to cognitive, neurologic or psychiatric impairment. * Lobar or segmental stents alone * Terminally ill patients considered too sick to undergo a follow-up surveillance bronchoscopy * Stent insertion as a trial for excessive central airway collapse (as the duration of these stents is only 1-2 weeks) * Patients with a tracheostomy (as these patients can undergo frequent in-line suctioning that can affect the outcomes being assessed)

Inclusion Criteria

Exclusion Criteria

* All adult patients that undergo central airway (trachea, main stem bronchi and bronchus intermedius) stenting.

* Inability to obtain informed consent due to cognitive, neurologic or psychiatric impairment.
* Lobar or segmental stents alone
* Terminally ill patients considered too sick to undergo a follow-up surveillance bronchoscopy
* Stent insertion as a trial for excessive central airway collapse (as the duration of these stents is only 1-2 weeks)
* Patients with a tracheostomy (as these patients can undergo frequent in-line suctioning that can affect the outcomes being assessed)

Contacts and Locations

Study Contact

Axel Duval, MD

CONTACT

‭(212) 824-8546‬

axel.duval@mountsinai.org

Principal Investigator

Udit Chaddha, MBBS

PRINCIPAL_INVESTIGATOR

Icahn School of Medicine

Study Locations (Sites)

The Mount Sinai Health System

New York, New York, 10029

United States

Collaborators and Investigators

Sponsor: Icahn School of Medicine at Mount Sinai

Udit Chaddha, MBBS, PRINCIPAL_INVESTIGATOR, Icahn School of Medicine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-01-01

Study Completion Date2026-03-31

Study Record Updates

Study Start Date2025-01-01

Study Completion Date2026-03-31

Terms related to this study

Keywords Provided by Researchers

Airway
Stent
Bronchoscopy
Surveillance

Additional Relevant MeSH Terms

Bronchial Stents